CPH Specialty Pharma Investor Presentation December 2023

Specialty pharmaceutical company presentation outlining a lean operating model focused on acquiring and licensing Rx medicines with partner commercialization. The company emphasizes cash generation, infrastructure-light portfolio management, and development in specialized therapeutic areas with favorable risk/return profiles.